- Home
- PT vs NCNA Comparison
PT vs NCNA Comparison
Compare PT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PT
- NCNA
- Stock Information
- Founded
- PT 2012
- NCNA 1997
- Country
- PT China
- NCNA United Kingdom
- Employees
- PT N/A
- NCNA N/A
- Industry
- PT Computer Software: Programming Data Processing
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- PT Technology
- NCNA Health Care
- Exchange
- PT Nasdaq
- NCNA Nasdaq
- Market Cap
- PT 15.2M
- NCNA 15.4M
- IPO Year
- PT 2018
- NCNA 2017
- Fundamental
- Price
- PT $0.98
- NCNA $4.02
- Analyst Decision
- PT
- NCNA Buy
- Analyst Count
- PT 0
- NCNA 2
- Target Price
- PT N/A
- NCNA $5,000.00
- AVG Volume (30 Days)
- PT 7.9K
- NCNA 1.1M
- Earning Date
- PT 08-26-2025
- NCNA 08-26-2025
- Dividend Yield
- PT N/A
- NCNA N/A
- EPS Growth
- PT N/A
- NCNA N/A
- EPS
- PT N/A
- NCNA N/A
- Revenue
- PT $4,814,566.00
- NCNA N/A
- Revenue This Year
- PT N/A
- NCNA N/A
- Revenue Next Year
- PT N/A
- NCNA N/A
- P/E Ratio
- PT N/A
- NCNA N/A
- Revenue Growth
- PT N/A
- NCNA N/A
- 52 Week Low
- PT $0.76
- NCNA $3.72
- 52 Week High
- PT $1.15
- NCNA $2,158.00
- Technical
- Relative Strength Index (RSI)
- PT 53.96
- NCNA 30.75
- Support Level
- PT $0.88
- NCNA $3.72
- Resistance Level
- PT $0.98
- NCNA $5.70
- Average True Range (ATR)
- PT 0.05
- NCNA 1.01
- MACD
- PT 0.00
- NCNA -0.02
- Stochastic Oscillator
- PT 59.58
- NCNA 2.87
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.